Evidence map›Paper›PMID 21277193›Full record

ReviewCurrent opinion in genetics & development2011

The genetics of Tourette disorder.

Matthew W State

Abstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Networks in the Field of Tourette Syndrome.Frontiers in neurology · 2021
    Review
  4. Genetic Approaches to Understanding Psychiatric Disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2014
    Article
  13. Review
  14. Article
  15. Article
  16. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.Movement disorders : official journal of the Movement Disorder Society · 2013
    Article
  17. Genetic susceptibility and neurotransmitters in Tourette syndrome.International review of neurobiology · 2013
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Matthew W StateDepartment of Child Psychiatry, Yale University School of Medicine, New Haven, CT 06520, United States. Matthew.State@yale.edu
Yale University · US

Funding

The Role of SLITRK1 in Tourette and Related DisordersR01NS056276 · NINDS · YALE UNIVERSITY · PI STATE, MATTHEW W. · 2006 to 2010
$2.1M
NINDS NIH HHS NS056276NINDS NIH HHS R01 NS056276
6 · The paper itself

Abstract

Tourette disorder (TD) is a childhood onset neuropsychiatric syndrome defined by persistent motor and vocal tics. Despite a long-standing consensus for a strong genetic contribution, the pace of discovery compared to other disorders of similar prevalence has been slow, due in part to a paucity of studies and both clinical heterogeneity and a complex genetic architecture. However, the potential for rapid progress is high. Recent rare variant findings have pointed to the importance of copy number variation, the overlap of risks among distinct diagnostic entities, the contribution of novel molecular mechanisms, and the value of family based studies. Finally, analysis of a cohort of sufficient size to identify common polymorphisms of plausible effect is underway, promising key information regarding the contribution of common alleles to TD.

Indexed as

Chromosome AberrationsDNA Copy Number VariationsGenetic Association StudiesGenetic LinkageHumansTicsTourette Syndrome

Identifiers

PMID21277193
PMCPMC3102152
OpenAlexW2016864963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.